MAHON PAUL A

PrivateCIK: 1231589

Senior insider sale

EVP & GENERAL COUNSEL at UNITED THERAPEUTICS CORP — senior position signals high conviction

$27.43M

49.80K shares

What this filing means

MAHON PAUL A plans to sell 49.80K shares of UNITED THERAPEUTICS CORP valued at approximately $27.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderMAHON PAUL ACIK 1231589
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Officer· EVP & GENERAL COUNSEL
Since Mar 2026
49.80K
Shares to sell
$27.43M
Approx. market value
8.30K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Sort

Stock Option Exercise

Cash

5/21/2026
8.30K
Total acquired8.30K
Planned & Completed Dispositions6
Sort

Completed

Completed

Units to sell

8.30K

Market value

$4.87M

5/7/2026
Completed

Units to sell

8.30K

Market value

$4.79M

4/16/2026
Completed

Units to sell

8.30K

Market value

$4.70M

4/2/2026
Completed

Units to sell

8.30K

Market value

$4.40M

3/19/2026
Completed

Units to sell

8.30K

Market value

$4.01M

3/5/2026

Planned — Approximate Date

NASDAQPlanned

Units to sell

8.30K

Market value

$4.67M

5/21/2026
Total

Units

49.80K

Value

$27.43M

MAHON PAUL A — Planned Insider Sale (Form 144) | Finecho